Re-live UEG Week

UEG Week edition 2024

UEG Week 2026 UEG Week 2025 UEG Week 2024 UEG Week 2023

until 09:30 · A1 PGT 4 on Gutflix

Upper gastrointestinal bleeding: Improve your knowledge

until 09:30 · A3 PGT 5 on Gutflix

Advanced diagnostic endoscopy

until 09:30 · C1/4 PGT 4 on Gutflix

IBS: Tips and tricks for the busy clinician

until 09:30 · Strauss 1 PGT 4 on Gutflix

Diagnosis and treatment of malnutrition

until 09:30 · Strauss 2 PGT 5 on Gutflix

Liver lesions: When to call the radiologist

more in parallel Show fewer

until 09:30 · A1 3 on Gutflix

GI cancer in Africa

until 09:30 · A2 3 on Gutflix

Focus on personalised approaches in IBD

until 09:30 · A3 5 on Gutflix

Ameliorating acute disease through novel treatment in IBD: Part 1

until 09:30 · A8 4 on Gutflix

A topic we don't talk about: Evacuation disorders

until 09:30 · A9 3 on Gutflix

Advanced techniques for advanced upper GI cancer

until 09:30 · C1/4 3 on Gutflix

Update on the management of patients with cirrhosis

until 09:30 · Lehar 1 5 on Gutflix

Obesity: Endoscopy and drugs

until 09:30 · Lehar 2 5 on Gutflix

Upper GI basic: Reflux, gastritis and cancer

until 09:30 · Lehar 3 5 on Gutflix

Recent break throughs in treating and monitoring MASH

until 09:30 · Strauss 1 3 on Gutflix

Crash course: Malabsorption

until 09:30 · Strauss 2 3 on Gutflix

Minimally invasive techniques in pancreatic disease

until 09:30 · Strauss 3 2 on Gutflix

My bum hurts: Painful proctology

more in parallel Show fewer

until 09:30 · A1 5 on Gutflix

Optimising biological treatment in IBD

until 09:30 · A2 3 on Gutflix

Crash course: Checkpoint inhibitors - a double-edged sword

until 09:30 · A3 1 on Gutflix

ESGE Live Endoscopy I

until 09:30 · A8 2 on Gutflix

Disease primer: IBD - IBS

until 09:30 · A9 3 on Gutflix

Fibrosis: Healing, scaring or driving disease

until 09:30 · C1/4 4 on Gutflix

Advances in metabolic disorders: Treatment of metabolic disease - learn from the experts

until 09:30 · Lehar 1 5 on Gutflix

Short bowel syndrome

until 09:30 · Lehar 2 5 on Gutflix

Fit for CRC screening

until 09:30 · Lehar 3 5 on Gutflix

What's new in acute pancreatitis

until 09:30 · Strauss 1 5 on Gutflix

Microbiome: Bench to the future

until 09:30 · Strauss 2 6 on Gutflix

From IBS and IBD: Late-breaking abstracts

until 09:30 · Strauss 3 5 on Gutflix

Pancreatic cancer: Extending life expectancy

more in parallel Show fewer

until 10:30 · C1/4 PGT 4 on Gutflix

Metabolic dysfunction: Associated steatotic liver disease

until 10:30 · Lehar 3 4 on Gutflix

ESGENA Opening Session: Be aware of AI in endoscopy nursing

until 11:30 · A1 PGT 5 on Gutflix

CRC: It's all about screening

until 11:00 · A2 1 on Gutflix

Oral Advanced Therapies in UC: Are More Options Needed? (Abivax)

until 11:30 · A3 PGT 5 on Gutflix

A personalised approach to chronic pancreatitis

until 11:30 · C1/4 PGT 3 on Gutflix

Exploring the onset: Insights into early IBD

until 11:30 · Lehar 2 6 on Gutflix

Abstracts II: Patient care and endoscopic techniques

until 11:30 · Lehar 3 4 on Gutflix

Management: Increase staff wellbeing

until 11:30 · Strauss 1 PGT 5 on Gutflix

Promoting rehabilitation and longevity in chronic intestinal failure

until 11:30 · Strauss 2 PGT 4 on Gutflix

Update on management of viral hepatitis

more in parallel Show fewer

until 11:00 · A1 6 on Gutflix

Crohn’s disease hot of the press: Late-breaking abstracts

until 11:00 · A2 3 on Gutflix

Pushing the boundaries in hepatocellular carcinoma treatment

until 11:00 · A3 3 on Gutflix

Acute pancreatitis: Still devastating outcomes

until 11:00 · A8 2 on Gutflix

Disease primer: Clinical and molecular stratification in HPB

until 11:00 · A9 3 on Gutflix

How to overcome chronic abdominal pain

until 11:00 · C1/4 3 on Gutflix

IBD: Postoperative recurrence

until 11:00 · Lehar 1 4 on Gutflix

Basic mechanisms of disease in liver, pancreas and intestine

until 11:00 · Lehar 2 4 on Gutflix

AI and reflux

until 11:00 · Lehar 3 5 on Gutflix

IBD: New horizons in medical treatment - Part 1

until 11:00 · Strauss 1 5 on Gutflix

Diagnose and treat to target in GI cancer: Latest news

until 11:00 · Strauss 2 3 on Gutflix

Neuroendocrine neoplasms: The zebras of the cancer world

until 11:00 · Strauss 3 3 on Gutflix

Drugs and microbiota

more in parallel Show fewer

until 11:00 · A1 5 on Gutflix

Mistakes in...: Upper GI

until 11:00 · A2 3 on Gutflix

Advances in metabolic disorders: Liver injury - prevent or rescue

until 11:00 · A3 1 on Gutflix

ESGE Live Endoscopy II

until 11:00 · A8 5 on Gutflix

Motility disorders: Is endoscopy the cure?

until 11:00 · A9 3 on Gutflix

Never waste a good disaster: Lower GI

until 11:00 · C1/4 4 on Gutflix

Therapy update: IBD

until 11:00 · Lehar 1 5 on Gutflix

Screening colonoscopy: How to save lives

until 11:00 · Lehar 2 5 on Gutflix

Trends in hepatology: From diagnosis to treatment

until 11:00 · Lehar 3 5 on Gutflix

Finetuning treatment in IBD

until 11:00 · Strauss 1 3 on Gutflix

Treat to target in GI cancer

until 11:00 · Strauss 2 3 on Gutflix

Hot Topics from Pan America: An update on coeliac disease

until 11:00 · Strauss 3 5 on Gutflix

IBD: Diagnosis and monitoring

more in parallel Show fewer

until 12:30 · A1 PGT 5 on Gutflix

What’s new in extra-intestinal manifestations of IBD?

until 12:30 · A3 PGT 5 on Gutflix

Tips and tricks for liver function testing

until 12:30 · C1/4 PGT 4 on Gutflix

Management of pancreatic diseases: Knife or scope?

until 12:30 · Lehar 2 5 on Gutflix

New trends and developments in hygiene and infection control

until 12:30 · Lehar 3 6 on Gutflix

New trends and developments in endoscopic techniques

until 12:30 · Strauss 1 PGT 5 on Gutflix

Antibiotic-associated diarrhoea: Sudden disruption of a healthy ecosystem

until 12:30 · Strauss 2 PGT 5 on Gutflix

Benign dysphagia: Hard to swallow?

more in parallel Show fewer

until 12:30 · A1 3 on Gutflix

Variceal bleeding: Help is on the way

until 12:30 · A2 4 on Gutflix

Mistakes in …: Hepatobiliary and pancreas

until 12:30 · A3 5 on Gutflix

Expanding treatment response in IBD

until 12:30 · A8 3 on Gutflix

What's new in H. pylori in 2024?

until 12:30 · A9 3 on Gutflix

Therapy update: Abdominal emergencies in gastroenterology

until 12:30 · C1/4 4 on Gutflix

IBD: A lifelong disease journey

until 12:30 · Lehar 1 5 on Gutflix

Optimising safety and efficacy of polyp treatment

until 12:30 · Lehar 2 5 on Gutflix

Microbiota, chronic inflammation and cancer

until 12:30 · Lehar 3 4 on Gutflix

Advanced ERCP technology and outcomes

until 12:30 · Strauss 1 3 on Gutflix

Single-cell transcriptomics in disease pathogenesis

until 12:30 · Strauss 2 3 on Gutflix

Small bowel functional disoders: From bacteria to transit

until 12:30 · Strauss 3 4 on Gutflix

Crash Course: Can we measure patients' needs in HPB?

more in parallel Show fewer

until 12:30 · A1 3 on Gutflix

Therapy update: Upper GI challenges

until 12:30 · A2 3 on Gutflix

What's new in transplantation medicine in 2024?

until 12:30 · A3 1 on Gutflix

ESGE Live Endoscopy III

until 12:30 · A8 3 on Gutflix

The patient with a challenging functional disorder

until 12:30 · A9 3 on Gutflix

The guilty genes in hereditary GI syndromes

until 12:30 · C1/4 3 on Gutflix

Advances in metabolic disorders: We talk about metabolic syndrome, but do we know what it is?

until 12:30 · Lehar 1 5 on Gutflix

Pancreatic diseases: From models to precision medicine

until 12:30 · Lehar 2 5 on Gutflix

AI in diagnostic and therapeutic endoscopy

until 12:30 · Lehar 3 5 on Gutflix

Eosinophilic oesophagitis

until 12:30 · Strauss 1 3 on Gutflix

Metabolism as a mechanism of disease

until 12:30 · Strauss 2 5 on Gutflix

IBD: New horizons in medical treatment - Part 2

until 12:30 · Strauss 3 2 on Gutflix

Disease primer: Neuro-immune dysfunction in disorders of the gut-brain axis

more in parallel Show fewer

until 13:00 · A1 1 on Gutflix

Future horizons: a glimpse into IL-23’s next chapter (Johnson and Johnson)

until 13:00 · A3 1 on Gutflix

Timely action in UC: Achieving mucosal healing to optimize patient outcomes (AbbVie)

until 13:00 · A8 1 on Gutflix

Inflammation in Crohn’s Disease: The Evolution Continues (Eli Lilly and Company)

until 13:00 · Lehar 2 3 on Gutflix

Communication team building and patient safety

until 13:00 · Lehar 3 3 on Gutflix

Sedation: Prevention of adverse events

until 13:00 · Strauss 1 1 on Gutflix

S1P Receptor Modulators in Ulcerative Colitis: A Growing Track Record in the Moderate UC Patient (Bristol Myers Squibb)

until 13:00 · Strauss 3 1 on Gutflix

Redefining EoE Control: Elevating Patient Lives Beyond Symptom Suppression (Sanofi Regeneron)

more in parallel Show fewer

until 14:00 · A1 1 on Gutflix

Connecting Dots: Integrating Recent Therapeutic Evidence of Subcutaneous Infliximab in the Treatment of IBD (Celltrion)

until 14:00 · A2 1 on Gutflix

Early & Sustained Control in UC: from trials to clinical practice with mirikizumab (Eli Lilly and Company)

until 14:00 · A3 1 on Gutflix

Timely action in CD: Why waiting is not an option (AbbVie)

until 14:00 · A8 1 on Gutflix

Symptomatic diverticular disease

until 14:00 · Lehar 3 1 on Gutflix

Something to Chew On: Exploring Biologics in the Management of EoE (Sanofi Regeneron)

until 14:00 · Strauss 1 1 on Gutflix

Eosinophilic Esophagitis: Current Perspectives and Future Directions (Bristol Myers Squibb)

until 14:00 · Strauss 2 1 on Gutflix

Endoscopic management of choledocholithiasis

until 14:00 · Strauss 3 1 on Gutflix

From acute to chronic pancreatitis

more in parallel Show fewer

until 14:00 · A2 1 on Gutflix

A series of unfortunates events: IBD, flares and CDI (Tillotts Pharma AG)

until 14:00 · A8 1 on Gutflix

Managing IBD in the elderly

until 14:00 · Strauss 2 1 on Gutflix

T1b squamous cancer

until 14:00 · Strauss 3 1 on Gutflix

Precancerous ampullary lesions

more in parallel Show fewer

until 15:00 · A1 PGT 6 on Gutflix

Personalised therapy in locally advanced pancreatic cancer

until 15:00 · A3 PGT 4 on Gutflix

Management of GORD in 2024

until 15:00 · C1/4 PGT 6 on Gutflix

Endoscopic treatment and prognosis of GI diseases

until 15:00 · Lehar 2 4 on Gutflix

Liver nurses: Advanced roles improve patient outcome

until 15:00 · Lehar 3 6 on Gutflix

Abstracts I: Management and education

until 15:00 · Strauss 1 PGT 5 on Gutflix

ABC of the EAS and the IAS: Why physiology matters when managing faecal incontinence

until 15:00 · Strauss 2 PGT 4 on Gutflix

Biliary strictures: Getting through without getting lost

more in parallel Show fewer

until 15:00 · C1/4 9 on Gutflix

Opening Plenary

until 14:30 · Lehar 2 3 on Gutflix

My worst case and what I have learned from it

until 14:30 · Lehar 3 3 on Gutflix

Education: Creative tools

until 15:30 · A1 3 on Gutflix

Advanced cellular therapies in IBD

until 15:30 · A2 2 on Gutflix

Therapy update: Treatment of obesity

until 15:30 · A3 3 on Gutflix

Biliary drainage in altered anatomy

until 15:30 · A8 3 on Gutflix

Therapy update: Autoimmunity in GI

until 15:30 · A9 3 on Gutflix

Quality in upper GI: The good, the bad and the ugly

until 15:30 · C1/4 5 on Gutflix

Maintaining remission and quality of life in IBD

until 15:30 · Lehar 1 5 on Gutflix

Barrett's oesophagus: Treatment and surveillance

until 15:30 · Lehar 2 5 on Gutflix

IBS: Emerging evidence for treatment

until 15:30 · Lehar 3 5 on Gutflix

AI for polyp detection: Advances, pitfalls and challenges

until 15:30 · Strauss 1 3 on Gutflix

Molecular stratification of GI cancer: What every gastroenterologist should know

until 15:30 · Strauss 2 5 on Gutflix

Understanding disease primers of IBD: Part 2

until 15:30 · Strauss 3 3 on Gutflix

AI in HPB: Hype or hope?

more in parallel Show fewer

until 15:30 · A1 6 on Gutflix

Between liver and pancreas - Game on: Late-breaking abstracts

until 15:30 · A2 3 on Gutflix

What's new in AI in lower GI in 2024?

until 15:30 · A3 3 on Gutflix

From guidelines to clinical practice: Upper GI

until 15:30 · A8 3 on Gutflix

Is IBS a gut-specific disease or a multisystem disorder?

until 15:30 · A9 3 on Gutflix

Screening and surveillance of colorectal neoplasia

until 15:30 · C1/4 3 on Gutflix

What's new in IBD in 2024?

until 15:30 · Lehar 1 5 on Gutflix

Upper GI bleeding: Treatment and outcome

until 15:30 · Lehar 2 5 on Gutflix

Local treatment for locally advanced colon cancer: How to improve outcome

until 15:30 · Lehar 3 5 on Gutflix

Pancreatic endoscopy and patient outcome

until 15:30 · Strauss 1 3 on Gutflix

Update on eosinophilic oesophagitis

until 15:30 · Strauss 2 3 on Gutflix

What's new in future molecular therapies in GI cancer in 2024?

until 15:30 · Strauss 3 5 on Gutflix

IBD: A burden for patient and society

more in parallel Show fewer

until 17:00 · A1 PGT 5 on Gutflix

FD and gastroparesis: It can be easy if you do it smart

until 17:00 · A3 PGT 5 on Gutflix

Benign diseases of the bile duct

until 17:00 · C1/4 PGT 5 on Gutflix

Decision time in IBD: Difficult cases

until 17:00 · Lehar 2 3 on Gutflix

IBD nurses: All around the gut

until 17:00 · Lehar 3 4 on Gutflix

Sustainability and hygiene: Implementation of new projects

until 17:00 · Strauss 1 PGT 6 on Gutflix

How to treat itching?

until 17:00 · Strauss 2 PGT 4 on Gutflix

When the bowel loses its flow

more in parallel Show fewer

until 16:30 · A1 3 on Gutflix

Controversies in the management of colorectal neoplasia

until 16:30 · A2 4 on Gutflix

From guidelines to clinical practice: HPB

until 16:30 · A3 3 on Gutflix

Never waste a good disaster: Upper GI

until 16:30 · A8 4 on Gutflix

From frequent to rare: Update on the liver disease landscape

until 16:30 · A9 3 on Gutflix

When things get shitty: Diarrhoea

until 16:30 · C1/4 3 on Gutflix

IBD: Maximising therapy success

until 16:30 · Lehar 1 5 on Gutflix

Dyspepsia and H.pylori

until 16:30 · Lehar 2 5 on Gutflix

Pancreatic diseases: From mechanisms to therapy

until 16:30 · Lehar 3 5 on Gutflix

Understanding disease primers of IBD: Part 1

until 16:30 · Strauss 1 3 on Gutflix

Microbiota in diagnostics

until 16:30 · Strauss 2 3 on Gutflix

Diagnosis and management of GORD: The lyon is in the room!

until 16:30 · Strauss 3 4 on Gutflix

Coeliac disease

more in parallel Show fewer

until 17:00 · A1 3 on Gutflix

What's new in AI for upper GI in 2024?

until 17:00 · A2 3 on Gutflix

From guidelines to clinical practice: Lower GI

until 17:00 · A3 5 on Gutflix

Ameliorating acute disease through novel treatment in IBD: Part 2

until 17:00 · A8 3 on Gutflix

Incidental findings in HPB: When are they clinically relevant?

until 17:00 · A9 3 on Gutflix

Nutrition in pathogenesis and treatment of lower GI disorders

until 17:00 · C1/4 3 on Gutflix

Therapy update: Is en-bloc the new standard for colorectal polyps

until 17:00 · Lehar 1 5 on Gutflix

Pancreatic cancer: From bench to bedside

until 17:00 · Lehar 2 4 on Gutflix

H.pylori basics

until 17:00 · Lehar 3 3 on Gutflix

EMR or ESD for colon neoplasia

until 17:00 · Strauss 1 3 on Gutflix

Future microbiome therapeutics

until 17:00 · Strauss 2 3 on Gutflix

Rising Stars from Europe and Japan: GI cancer

until 17:00 · Strauss 3 3 on Gutflix

Breaking news in coeliac disease

more in parallel Show fewer

until 18:00 · A1 5 on Gutflix

IBD: Latest news on a personalised approach

until 18:00 · A2 4 on Gutflix

Mistakes in...: Lower GI

until 18:00 · A3 6 on Gutflix

Bugs and germs in GI-disease: Late-breaking abstracts

until 18:00 · A8 5 on Gutflix

Best of DDW

until 18:00 · A9 3 on Gutflix

Never waste a good disaster: HPB

until 18:00 · C1/4 3 on Gutflix

IBD-associated colorectal cancer: Under- or overestimated?

until 18:00 · Lehar 1 5 on Gutflix

Management of complications and endpoints in cirrhosis and HCC

until 18:00 · Lehar 2 4 on Gutflix

Upper GI endoscopy: From diagnosis to treatment

until 18:00 · Lehar 3 7 on Gutflix

Video Cases

until 18:00 · Strauss 1 5 on Gutflix

Microbiota driven carcinogenesis in GI disease

until 18:00 · Strauss 2 6 on Gutflix

UEG Journal Session

until 18:00 · Strauss 3 3 on Gutflix

Diagnosing and monitoring liver disease using novel biomarkers

more in parallel Show fewer

until 18:30 · Lehar 3 1 on Gutflix

Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis:Examining the Clinical Implications of Emerging Disease-Specific Therapies (Catalyst Medical Education, LLC.)

until 18:30 · Strauss 1 1 on Gutflix

Difficult-To-Treat Crohn’s Disease. From Monotherapy to Dual Targeted Therapy: Towards a New Paradigm? (Fresenius Kabi)